Clinical Trial Update: Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events

View source ↗

Summary

A completed clinical trial update examining the impact of renin-angiotensin-aldosterone system polymorphisms on resistant hypertension and adverse cardiovascula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Myocardial Infarction
• Resistant Hypertension
• Stroke

Snippet

Sponsor: Universidade Gama Filho | Conditions: Systemic Arterial Hypertension, Hypertension Resistant to Conventional Therapy | Status: COMPLETED | Results posted: 2013-03-06